SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001182489-17-000028
Filing Date
2017-01-11
Accepted
2017-01-11 17:56:46
Documents
1
Period of Report
2017-01-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 14090
  Complete submission text file 0001182489-17-000028.txt   15649
Mailing Address UNIT 5, SRAGH TECHNOLOGY PARK RAHAN ROAD TULLAMORE , CO. OFFALY L2 R35 FR98
Business Address UNIT 5, SRAGH TECHNOLOGY PARK RAHAN ROAD TULLAMORE , CO. OFFALY L2 R35 FR98 353 1 215 8100
Nexvet Biopharma plc (Issuer) CIK: 0001618561 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FARALLON CAPITAL MANAGEMENT, L.L.C. ONE MARITIME PLAZA, SUITE 2100 SAN FRANCISCO CA 94111
Business Address
Seybold William (Reporting) CIK: 0001693980 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36828 | Film No.: 17523647